| Trial ID: | L3040 |
| Source ID: | NCT04183257
|
| Associated Drug: |
Oral Vitamin D
|
| Title: |
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Vitamin D Deficiency|Insulin Resistance|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: oral vitamin D
|
| Outcome Measures: |
Primary: Homeostatic Model Assessment of Insulin Resistance, insulin resistance reduction to \<2.5, 3 months | Secondary: Glycated Hemoglobin (HbA1C), Reduction by 0.5%, 3 months
|
| Sponsor/Collaborators: |
Sponsor: King Edward Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
106
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-09-30
|
| Completion Date: |
2017-07-30
|
| Results First Posted: |
|
| Last Update Posted: |
2019-12-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT04183257
|
